Evaluation of a Novel System for Rapid Antibacterial Susceptibility Testing
Early determination of antibacterial susceptibility increases the success of therapy, decreases unnecessary use of antibacterial agents and side-effects, and lowers the overall healthcare cost. We have evaluated a rapid antibacterial susceptibility test, Qui-Sensitest (Salubris Inc., Istanbul, Turke...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Tehran University of Medical Sciences
2007-03-01
|
| Series: | Iranian Journal of Public Health |
| Subjects: | |
| Online Access: | https://ijph.tums.ac.ir/index.php/ijph/article/view/2917 |
| Summary: | Early determination of antibacterial susceptibility increases the success of therapy, decreases unnecessary use of antibacterial agents and side-effects, and lowers the overall healthcare cost. We have evaluated a rapid antibacterial susceptibility test, Qui-Sensitest (Salubris Inc., Istanbul, Turkey), which is based on a rapid culture medium that indicates growth by changing its color. Qui-Sensitest proved to be a reliable rapid test for determining antibacterial susceptibility having an overall agreement of 97.6% with Kirby Bauer disk diffusion test results for enteric bacteria with 0.4% of major discrepancies and 2.0% of minor discrepancy. Since the test makes the results available in 3.5-6 hours, it can provide the means for choosing the right treatment regimen the same day the infectious agent is isolated. |
|---|---|
| ISSN: | 2251-6085 2251-6093 |